Brian Ongioni, chief product officer, uMotif, discusses how AI and machine learning can enhance patient-reported outcomes by capturing meaningful feedback at scale and ensuring patient voices are ...

China-based MindRank’s oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has achieved up to 10.5% weight loss in a ...

Advarra, the market leader in regulatory review and clinical research technology, today announced the launch of the Council ...

| AI solutions in clinical trials are only as good as the data they process. With a focus on quality, AI can be harnessed to ...

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled ...

Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in participants.

By Hugo Francisco de Souza A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could offer new hope for idiopathic pulmonary fibrosis patients after demonstrating ...

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

CARY, NC / ACCESS Newswire / June 24, 2025 / Yunu, the creator and leader in cloud-native imaging workflows for clinical ...

Defining responsibilities for clinical information Over 100 AI scribe products are being marketed to healthcare services internationally.1234 Industry predictions speculate that up to 30% of ...